GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » BMP Pharma Trading AG (STU:BMP) » Definitions » EBIT

BMP Pharma Trading AG (STU:BMP) EBIT : €4.20 Mil (TTM As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is BMP Pharma Trading AG EBIT?

BMP Pharma Trading AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2024 was €1.49 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was €4.20 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. BMP Pharma Trading AG's annualized ROC % for the quarter that ended in Dec. 2024 was -9.62%. BMP Pharma Trading AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 1,570.53%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. BMP Pharma Trading AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 13.50%.

BMP Pharma Trading AG EBIT Historical Data

The historical data trend for BMP Pharma Trading AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BMP Pharma Trading AG EBIT Chart

BMP Pharma Trading AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 3.23 2.23 4.10 4.20

BMP Pharma Trading AG Semi-Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 2.35 1.76 2.71 1.49

Competitive Comparison of BMP Pharma Trading AG's EBIT

For the Medical Distribution subindustry, BMP Pharma Trading AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BMP Pharma Trading AG's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, BMP Pharma Trading AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where BMP Pharma Trading AG's EV-to-EBIT falls into.


;
;

BMP Pharma Trading AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €4.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BMP Pharma Trading AG  (STU:BMP) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

BMP Pharma Trading AG's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=-1.772 * ( 1 - 27.18% )/( (0 + 13.414)/ 1 )
=-1.2903704/13.414
=-9.62 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0 - ( 0 - max(0, 0 - 0+0))
=0

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=13.431 - 0.017 - ( 0 - max(0, 0.158 - 8.454+0))
=13.414

Note: The Operating Income data used here is two times the semi-annual (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

BMP Pharma Trading AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2.984/( ( (0 + max(0, 0)) + (0 + max(0.19, 0)) )/ 1 )
=2.984/( ( 0 + 0.19 )/ 1 )
=2.984/0.19
=1,570.53 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.222) - (0.017 + 0 + 0.015)
=0.19

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

BMP Pharma Trading AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=4.199/31.101
=13.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BMP Pharma Trading AG EBIT Related Terms

Thank you for viewing the detailed overview of BMP Pharma Trading AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

BMP Pharma Trading AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » BMP Pharma Trading AG (STU:BMP) » Definitions » EBIT
Comparable Companies
MCK COR CAH ASX:SIG HSIC SHSE:601607 HKSE:01099 SHSE:600332 XSWX:GALE MIL:AMP OSTO:ASKER NZSE:EBO SHSE:600998 TSE:7459 SHSE:600511 TSE:9987 TSE:2784 SHSE:600739 XKRX:008930 SHSE:600056
Traded in Other Exchanges
N/A
Address
Bornbarch 16, Norderstedt, SH, DEU, 22848
Website
https://www.bmp.ag
BMP Pharma Trading AG is a German company engaged in trading of pharmaceutical raw materials, food supplement products, and veterinary raw materials. The services offered by the company include development of microbial processes, Transfer of biotechnological processes, Contract production of biotechnologically and biocatalysts and development of chiral syntheses.

BMP Pharma Trading AG Headlines

No Headlines